DOSE-RESPONSE RELATIONSHIPS IN PROMOTION OF RAT HEPATOCARCINOGENESIS BY 17-ALPHA-ETHINYLESTRADIOL

被引:16
作者
CAMPEN, D [1 ]
MARONPOT, R [1 ]
LUCIER, G [1 ]
机构
[1] NIEHS,POB 12233,RES TRIANGLE PK,NC 27709
来源
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH | 1990年 / 29卷 / 03期
关键词
D O I
10.1080/15287399009531389
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
One of the critical issues in risk assessment for chemical carcinogens is the evaluation of dose-response relationships for tumor promoters. In the studies reported here we have systematically investigated dose-response relationships for the liver tumor- promoting actions of 17a-Ethinylestradiol (EE2) following a single injection of diethyl- nitrosamine (200 mg/kg) to ovariectomized female rats. Parameters measured included tumor incidence, gamma-glutamyltranspeptidase (GGT) positive foci, serum prolactin and serum EE2. The length of tumor promotion ranged from 30 to 60 wk. Results showed a linear increase in GGT-positive foci between doses of 16 and 90 ng EE2 kg/d for 30 wk. This was associated with corresponding increases in liver tumor incidence at 60 wk. Seventy-five percent of the animals had either hepatocellular adenoma or hepatocellular carcinoma in the group promoted with 90 fig EE^kg for 60 wk. No liver tumors were evident in either controls or animals receiving estrogen only. Serum prolactin concentrations were elevated in all estrogen-treated groups. In summary, our studies have evaluated dose-response relationships for GGT-positive foci and tumor incidence in a two-stage model for hepatocarcinogenesis using EE2 as the promoting agent. © 1975 Taylor & Francis Group, LLC.
引用
收藏
页码:257 / 268
页数:12
相关论文
共 37 条
[1]  
ALTMAN N, 1985, PATHOLOGY LABORATORY
[2]  
BAUM JK, 1973, LANCET, V2, P926
[3]  
Berenblum I, 1941, CANCER RES, V1, P44
[4]   BIOACTIVITY OF SERUM AND PITUITARY PROLACTIN DURING THE RAT ESTROUS-CYCLE [J].
BLANK, MS ;
CHING, MC ;
DUFAU, ML .
ENDOCRINOLOGY, 1986, 118 (05) :1886-1891
[5]   RAPID ELEVATION OF PLASMINOGEN-ACTIVATOR ACTIVITY IN RAT-TISSUES BY PROLACTIN [J].
BUCKLEY, AR ;
PUTNAM, CW ;
RUSSELL, DH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 122 (03) :1005-1011
[6]   PROLACTIN ADMINISTRATION STIMULATES RAT HEPATIC DNA-SYNTHESIS [J].
BUCKLEY, AR ;
PUTNAM, CW ;
MONTGOMERY, DW ;
RUSSELL, DH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 138 (03) :1138-1145
[7]   PROLACTIN IS A TUMOR PROMOTER IN RAT-LIVER [J].
BUCKLEY, AR ;
PUTNAM, CW ;
RUSSELL, DH .
LIFE SCIENCES, 1985, 37 (26) :2569-2575
[8]   SEMICIRCADIAN RHYTHM IN PLASMA LEVELS OF PROLACTIN DURING EARLY GESTATION IN RAT [J].
BUTCHER, RL ;
COLLINS, WE ;
FUGO, NW .
ENDOCRINOLOGY, 1972, 90 (04) :1125-&
[9]  
CAMERON R, 1981, GANN, V72, P339
[10]  
CAMPEN DB, 1987, CANCER RES, V47, P2328